Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Roohi Ismail-Khan"'
Autor:
Melissa Y.Y. Moey, Cassandra Hennessy, Benjamin French, Jeremy L. Warner, Matthew D. Tucker, Daniel J. Hausrath, Dimpy P. Shah, Jeanne M. DeCara, Ziad Bakouny, Chris Labaki, Toni K. Choueiri, Susan Dent, Nausheen Akhter, Roohi Ismail-Khan, Lisa Tachiki, David Slosky, Tamar S. Polonsky, Joy A. Awosika, Audrey Crago, Trisha Wise-Draper, Nino Balanchivadze, Clara Hwang, Leslie A. Fecher, Cyndi Gonzalez Gomez, Brandon Hayes-Lattin, Michael J. Glover, Sumit A. Shah, Dharmesh Gopalakrishnan, Elizabeth A. Griffiths, Daniel H. Kwon, Vadim S. Koshkin, Sana Mahmood, Babar Bashir, Taylor Nonato, Pedram Razavi, Rana R. McKay, Gayathri Nagaraj, Eric Oligino, Matthew Puc, Polina Tregubenko, Elizabeth M. Wulff-Burchfield, Zhuoer Xie, Thorvardur R. Halfdanarson, Dimitrios Farmakiotis, Elizabeth J. Klein, Elizabeth V. Robilotti, Gregory J. Riely, Jean-Bernard Durand, Salim S. Hayek, Lavanya Kondapalli, Stephanie Berg, Timothy E. O'Connor, Mehmet A. Bilen, Cecilia Castellano, Melissa K. Accordino, Blau Sibel, Lisa B. Weissmann, Chinmay Jani, Daniel B. Flora, Lawrence Rudski, Miriam Santos Dutra, Bouganim Nathaniel, Erika Ruíz-García, Diana Vilar-Compte, Shilpa Gupta, Alicia Morgans, Anju Nohria
Publikováno v:
Translational Oncology, Vol 34, Iss , Pp 101709- (2023)
Background: Data regarding outcomes among patients with cancer and co-morbid cardiovascular disease (CVD)/cardiovascular risk factors (CVRF) after SARS-CoV-2 infection are limited. Objectives: To compare Coronavirus disease 2019 (COVID-19) related co
Externí odkaz:
https://doaj.org/article/9d648aa2b95644a1af71f1806e404101
Autor:
Jamila Mammadova, Anna Redden, Rachel Cruz, Boglarka Ujhazi, Sumai Gordon, Maryssa Ellison, Tyra Gatewood, Carla Duff, Anthony Cannella, Charurut Somboonwit, Chakrapol Sriaroon, Krisztian Csomos, Joseph F. Dasso, Terry Harville, Roohi Ismail-Khan, Jolan E. Walter
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/57edda25ef6943f49784cb9fef19f679
Autor:
Jamila Mammadova, Anna Redden, Rachel Cruz, Boglarka Ujhazi, Sumai Gordon, Maryssa Ellison, Tyra Gatewood, Carla Duff, Anthony Cannella, Charurut Somboonwit, Chakrapol Sriaroon, Krisztian Csomos, Joseph F. Dasso, Terry Harville, Roohi Ismail-Khan, Jolan E. Walter
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPatients with inborn errors of immunity (IEI) have increased risk of developing cancers secondary to impaired anti-tumor immunity. Treatment of patients with IEI and cancer is challenging as chemotherapy can exacerbate infectious susceptibi
Externí odkaz:
https://doaj.org/article/ec47ad3c7ce941f89a295e82ec822159
Autor:
Michael G. Fradley, Mohammed Alomar, Marcus W. Kilpatrick, Bernadette Shields, Nhi Tran, Amey Best, Erika Bianco, Merna Armanious, R. Ashton Vautier, Kevin Kip, Theresa M. Beckie, Roohi Ismail-Khan
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Objective Women with breast cancer (BCA) and cardiovascular disease (CVD) risk factors are at increased risk of developing cardiovascular complications when exposed to potentially cardiotoxic cancer therapy. The benefit of aggressive CVD ris
Externí odkaz:
https://doaj.org/article/9a0205e86ba641babbadd2e182249657
Autor:
Diego Sadler, Jeanne M. DeCara, Joerg Herrmann, Anita Arnold, Arjun K. Ghosh, Husam Abdel-Qadir, Eric H. Yang, Sebastian Szmit, Nausheen Akhter, Monika Leja, Carolina Maria Pinto Domingues Carvalho Silva, Jayant Raikhelkar, Sherry-Ann Brown, Susan Dent, Rupal O’Quinn, Franck Thuny, Rohit Moudgil, Luis E. Raez, Tochukwu Okwuosa, Andres Daniele, Brenton Bauer, Lavanya Kondapalli, Roohi Ismail-Khan, Jorge Lax, Anne Blaes, Zeina Nahleh, Leah Elson, Lauren A. Baldassarre, Vlad Zaha, Vijay Rao, Daniel Sierra Lara, Kerry Skurka, on behalf of the Cardio-Oncology International Collaborative Network
Publikováno v:
Cardio-Oncology, Vol 6, Iss 1, Pp 1-13 (2020)
Abstract Background Re-allocation of resources during the COVID-19 pandemic has resulted in delays in care delivery to patients with cardiovascular disease and cancer. The ability of health care providers to provide optimal care in this setting has n
Externí odkaz:
https://doaj.org/article/3d53cbbe9da6429cb54c6ff34e368ba9
Autor:
Diego Sadler, MD, Michael G. Fradley, MD, Roohi Ismail-Khan, MD, MSC, Luis Raez, MD, Deepti Bhandare, MD, Leah Elson, MS, David Perloff, MD, Patricia Guerrero, MD, Zeina Nahleh, MD, Anita Arnold, DO
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 3, Pp 535-538 (2020)
Externí odkaz:
https://doaj.org/article/949509ee977444f0b342d08ccc327e05
Autor:
Michael G. Fradley, Allen C. Brown, Bernadette Shields, Federico Viganego, Rongras Damrongwatanasuk, Aarti A. Patel, Gregory Hartlage, Natalee Roper, Julie Jaunese, Larry Roy, Roohi Ismail-Khan
Publikováno v:
Oncology Reviews, Vol 11, Iss 2 (2017)
Cardio-oncology is a multidisciplinary field focusing on the management and prevention of cardiovascular complications in cancer patients and survivors. While the initial focus of this specialty was on heart failure associated with anthracycline use,
Externí odkaz:
https://doaj.org/article/3a32326c7ede4ab88ecb2bd26c9152de
Autor:
Patrick Neven, Nicole Stahl, Maria Vidal, Miguel Martín, Nadia Harbeck, Peter A. Kaufman, Francois-Clement Bidard, Peter A. Fasching, Philippe Aftimos, Erika Hamilton, Stacey Carter, Peter Schmid, Duncan Wheatley, Manali Bhave, Kelly K. Hunt, Swati A. Kulkarni, Roohi Ismail-Khan, Claudia Karacsonyi, Shawn T. Estrem, Umut Ozbek, Bastien Nguyen, Eva Ciruelos
Publikováno v:
Cancer Research. 83:P6-10
Background: Imlunestrant is a novel, orally bioavailable selective estrogen receptor degrader (SERD) with pure antagonistic properties that result in sustained inhibition of estrogen receptor (ER)-dependent gene transcription and cell growth. In a ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c184e561708d681fe7d140c24cd56f0f
https://doi.org/10.1158/1538-7445.sabcs22-p6-10-06
https://doi.org/10.1158/1538-7445.sabcs22-p6-10-06
Autor:
Jong Y. Park, Cecile A. Lengacher, Richard R. Reich, Hyun Y. Park, Junmin Whiting, Anh Thy Nguyen, Carmen Rodríguez, Hongdao Meng, Sara Tinsley, Katterine Chauca, Liliana Gordillo-Casero, Trudy Wittenberg, Anisha Joshi, Katherine Lin, Roohi Ismail-Khan, John V. Kiluk, Kevin E. Kip
Publikováno v:
Biological research for nursing. 24(4)
Introduction: Emerging evidence suggests that Chemotherapy (CT) treated breast cancer survivors (BCS) who have “risk variants” in genes may be more susceptible to cognitive impairment (CI) and/or poor cardiac phenotypes. The objective of this pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e27e6e0ea4d92cc039ea4e90e5517417
https://pubmed.ncbi.nlm.nih.gov/35499926
https://pubmed.ncbi.nlm.nih.gov/35499926
Autor:
Dejan Juric, Chong Ma, Ralph Tiedt, Yoon-Sim Yap, Joanne Chiu, Pamela Munster, Roohi Ismail-Khan, Laura Garcia-Estevez, Ingrid A. Mayer, Carlos Becerra, Nadia Solovieff, Agnes Lteif, Faye Su, Yen-Shen Lu
Publikováno v:
Cancer Research. 82:P5-13
Background: In addition to inhibiting cell cycle progression, CDK4/6 inhibitors have been found to modulate anti-cancer immune response (Goel S, et al. Nature. 2017;548:471-475). Data from preclinical studies suggested multiple mechanisms—involving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ef8917a1cf05f95e6fcb0ebd02b51f3
https://doi.org/10.1158/1538-7445.sabcs21-p5-13-18
https://doi.org/10.1158/1538-7445.sabcs21-p5-13-18